Epidemiology: Parkinson's Disease

Introduction

In this report, Datamonitor has estimated that there were a total of 1.5 million cases of Parkinson’s disease (PD) in 2010 in the seven major markets with nearly a third of them living in the US. Incidence rates are expected to remain constant, while total prevalence rates will increase as a result of the aging population in the seven major markets.
Features and benefits

* Gain insight to market potential, including a robust 10-year epidemiology forecast of prevalent Parkinson's disease cases.* Understand the key epidemiologic risk factors associated with Parkinson's disease.
Highlights

Datamonitor expects an increase in prevalent PD cases in the next decade in the seven major markets as a result of an ageing population.Parkinson’s disease is a lifelong incurable yet non-fatal disease; its disease progression leads to an increasing healthcare burden and lower quality of life.Age, family history and environmental exposures are important determining factors in PD prevalence and; with the exception of Japan, men are at a higher risk of developing PD in the six remaining major markets
Your key questions answered

* What are the most robust epidemiologic studies for Parkinson's disease prevalence data?* How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?* How do changes in population structure and risk factors affect the trend in prevalent Parkinson's disease cases?
[Studien Infos ausblenden]

Executive Summary
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Disease definition
GLOBAL VARIATION AND HISTORICAL TRENDS
Prevalence
Incidence
Survival
Mortality
CO-MORBIDITIES
Dementia
Physical and psychiatric co-morbidities
RISK FACTORS
Genetics and demographics
Age: strongest risk factor
Genetic predisposition: strong in patients under 50
Gender: more prevalent in males
Lifestyle factors
Lifestyle factors: role of smoking and diet
Other factors
Other factors: agricultural chemicals are strong predictors
EPIDEMIOLOGIC FORECASTING OF PARKINSON’S DISEASE
Sources of epidemiologic data
Description of methods
US
Japan
European markets
EPIDEMIOLOGIC RESULTS
Current prevalent cases and future trends
DISCUSSION
Strengths and limitations of our epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX A
Report methodology

[Inhaltsverzeichnis ausblenden]